{"id":"W2898290601","doi":"10.1093/annonc/mdy288.011","title":"First in human study with GSK3359609 [GSK609], inducible T cell co-stimulator (ICOS) receptor agonist in patients [Pts] with advanced, solid tumors: Preliminary results from INDUCE-1","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Adverse effect; Pembrolizumab; Nausea; Discontinuation; Agonist; Tolerability; Internal medicine; Toxicity; Immunotherapy; Oncology; Pharmacology; Receptor; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006654517,0.001110872,0.001133163,0.0002598057,0.0003748594,0.0006574995,0.0003948399,0.0007507152,0.003995719],"category_scores_gemma":[0.0006144049,0.0003007734,0.001048672,0.0002398821,0.0005696793,0.0006678451,0.0002193212,0.001651283,0.001333837],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000644206,"about_ca_system_score_gemma":0.0007388696,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007015931,"about_ca_topic_score_gemma":0.002157765,"domain_scores_codex":[0.9997172,0.0001170414,0.00001894798,0.0000557797,0.00002797532,0.00006304541],"domain_scores_gemma":[0.9996042,0.00006753874,0.00007767022,0.00006002325,0.00002639584,0.0001641422],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4389029,0.09753096,0.02499205,0.001453189,0.002359235,0.001493339,0.0008392355,0.002869457,0.1632429,0.0006443076,0.01466987,0.2510026],"study_design_scores_gemma":[0.1083391,0.8259415,0.03128748,0.00006583867,0.000725265,0.0009923578,0.0001085474,0.0008247218,0.02123027,0.0002637662,0.0101924,0.00002880448],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9863595,0.003140365,0.0009557492,0.0005402693,0.0001038393,0.001565976,0.001997546,0.0001585212,0.005178164],"genre_scores_gemma":[0.9896194,0.002213623,0.0007345702,0.0006404564,0.0001243974,0.0006445738,0.00244416,0.00004028765,0.003538544],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003995719,"threshold_uncertainty_score":0.013367,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07215735187253781,"score_gpt":0.3965070842453682,"score_spread":0.3243497323728304,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}